
EFFICACY OF AZITHROMYCIN IN THE TREATMENT OF CYCLOSPORINE-INDUCED GINGIVAL HYPERPLASIA IN RENAL TRANSPLANT RECIPIENTS1,2
Author(s) -
Michelle M. Nash,
Jeffrey Zaltzman
Publication year - 1998
Publication title -
transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.45
H-Index - 204
eISSN - 1534-6080
pISSN - 0041-1337
DOI - 10.1097/00007890-199806270-00012
Subject(s) - medicine , interdental consonant , azithromycin , gingival sulcus , dentistry , hyperplasia , placebo , antibiotics , pathology , alternative medicine , microbiology and biotechnology , biology
Gingival hyperplasia (GH) is a common side effect of cyclosporine . Azithromycin (Zithromax; AZI) is a macrolide antibiotic reported in case studies to reduce cyclosporine-induced gingival hyperplasia (CIGH) in renal transplant recipients (RTR).